YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017

This table browses all dspace content
Issue Date	Title	Journal Title
2026	LOw-Dose RAbeprazole Therapy for Reducing Gastrointestinal Events in Patients with High Bleeding Risk (LORA-HBR): A Prospective, Multicenter, Interventional Study	JOURNAL OF CLINICAL MEDICINE
2026	A Response to the Letter to the Editor: "Comment on COCOON: Daily 4% Chlorhexidine for Nail Care-Rationale, Safety, and Evidence Gaps"	JOURNAL OF THORACIC ONCOLOGY
2026	Pregnancy Outcomes After HIV Diagnosis in Women Living With HIV in Japan, South Korea and Hong Kong Special Administrative Region: A Brief Report	PEDIATRIC INFECTIOUS DISEASE JOURNAL
2026	Endoscopic Diagnosis of Eosinophilic Esophagitis Using a Multi-Task U-Net: A Pilot Study	YONSEI MEDICAL JOURNAL
2026	Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer	ESMO OPEN
2026	Diagnostic Performance of Angiography-Derived FFR According to the Analysis Factors	KOREAN CIRCULATION JOURNAL
2026	Steatosis-Associated Fibrosis Estimator Score in Asian Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease	YONSEI MEDICAL JOURNAL
2026	Increased risks associated with large endoscopic sphincterotomy combined with endoscopic papillary large balloon dilation	GASTROINTESTINAL ENDOSCOPY
2026	Post-transplant outcomes by bridging strategy: A nationwide multicenter study of heart transplant recipients in Korea	JOURNAL OF HEART AND LUNG TRANSPLANTATION
2026	Integration of PNPLA3 and TM6SF2 genotypes provides incremental improvement in advanced fibrosis prediction among MASLD patients with type 2 diabetes mellitus	JHEP REPORTS
2026	Plain language summary of TASUKI-52: A study looking at nivolumab plus platinum chemotherapy and bevacizumab as a combined treatment for people with advanced or recurrent nonsquamous non-small cell lung cancer (NSCLC)	FUTURE ONCOLOGY
2026	Overall survival with abemaciclib in early breast cancer	ANNALS OF ONCOLOGY
2026	Efficacy and safety of a novel sodium picosulfate oral tablet in a randomized controlled trial for bowel preparation	WORLD JOURNAL OF GASTROENTEROLOGY
2026	CO2 inhalation enhances pericyte-mediated neurovascular protection in ischemic stroke and remains safe in hemorrhagic stroke	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
2026	A Phase III Randomized Controlled Trial Evaluating the Efficacy and Safety of Azilsartan Medoxomil and Amlodipine Combination Therapy in Patients With Mild-to-Moderate Essential Hypertension Inadequately Controlled on Monotherapy	CLINICAL THERAPEUTICS
2026	Evaluation of diastolic function: machine learning improves classification of left ventricular filling pressure	EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING
2026	Molecular analysis of the interaction between ubiquitin-specific protease 7 and large T antigen of Merkel cell polyomavirus	JOURNAL OF MICROBIOLOGY
2026	Prognostic Value of Left Atrial Strain for Systemic Embolism in Rheumatic Mitral Stenosis with Sinus Rhythm: Implications for Anticoagulation Strategy	JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
2026	Effectiveness and Safety of COVID-19 Vaccination in Patients With Heart Failure: A Nationwide Retrospective Cohort Study	KOREAN CIRCULATION JOURNAL
2026	Novel pembrolizumab-based treatments as first-line therapy in advanced clear-cell renal cell carcinoma: substudy 03A of the open-label, umbrella platform, phase I/II KEYMAKER-U03 trial	ANNALS OF ONCOLOGY